Drug development for the treatment of RyR1-related skeletal muscle diseases

被引：9

作者：

Murayama, Takashi ^{[1
]}

Kurebayashi, Nagomi ^{[1
]}

Ishida, Ryosuke ^{[2
]}

Kagechika, Hiroyuki ^{[2
]}

机构：

[1] Juntendo Univ, Dept Pharmacol, Sch Med, Tokyo, Japan

[2] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan

来源：

CURRENT OPINION IN PHARMACOLOGY | 2023年 / 69卷

关键词：

CENTRAL CORE DISEASE; MALIGNANT HYPERTHERMIA; RYANODINE RECEPTOR; CALCIUM-RELEASE; CONGENITAL MYOPATHIES; MOLECULAR-MECHANISM; DANTROLENE; RYR1; CHANNEL; MUTATIONS;

D O I：

10.1016/j.coph.2023.102356

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Type 1 ryanodine receptor (RyR1) is an intracellular Ca2+ release channel on the sarcoplasmic reticulum of skeletal muscle, and it plays a central role in excitation-contraction (E-C) coupling. Mutations in RyR1 are implicated in various muscle diseases including malignant hyperthermia, central core disease, and myopathies. Currently, no specific treatment exists for most of these diseases. Recently, high-throughput screening (HTS) assays have been developed for identifying potential candidates for treating RyR-related muscle diseases. Currently, two different methods, namely a FRET-based assay and an endoplasmic reticulum Ca2+-based assay, are avail-able. These assays identified several compounds as novel RyR1 inhibitors. In addition, the development of a reconstituted platform permitted HTS assays for E-C coupling modulators. In this review, we will focus on recent progress in HTS assays and discuss future perspectives of these promising approaches.

引用

页数：7

共 50 条

[41] Functional impairments, fatigue and quality of life in RYR1-related myopathies: A questionnaire study [J].

van Ruitenbeek, E. ;

Custers, J. A. E. ;

Verhaak, C. ;

Snoeck, M. ;

Erasmus, C. E. ;

Kamsteeg, E. J. ;

Schouten, M., I ;

Coleman, C. ;

Treves, S. ;

van Engelen, B. G. ;

Jungbluth, H. ;

Voermans, N. C. .

NEUROMUSCULAR DISORDERS, 2019, 29 (01) :30-38

[42] Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel [J].

Godbout, Kelly ;

Dugas, Mathieu ;

Reiken, Steven R. ;

Ramezani, Sina ;

Falle, Alexia ;

Rousseau, Joel ;

Wronska, Anetta E. ;

Lamothe, Gabriel ;

Canet, Geoffrey ;

Lu, Yaoyao ;

Planel, Emmanuel ;

Marks, Andrew R. ;

Tremblay, Jacques P. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (07)

[43] Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy [J].

Capella-Peris, Carlos ;

Cosgrove, Mary M. ;

Chrismer, Irene C. ;

Emile-Backer, Magalie ;

Razaqyar, M. Sonia ;

Elliott, Jeffrey S. ;

Kuo, Anna ;

Wakim, Paul G. ;

Meilleur, Katherine G. .

QUALITY OF LIFE RESEARCH, 2020, 29 (06) :1641-1653

[44] RyR1-related myopathy mutations in ATP and calcium binding sites impair channel regulation [J].

Yuan, Qi ;

Dridi, Haikel ;

Clarke, Oliver B. ;

Reiken, Steven ;

Melville, Zephan ;

Wronska, Anetta ;

Kushnir, Alexander ;

Zalk, Ran ;

Sittenfeld, Leah ;

Marks, Andrew R. .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)

[45] Reliability and Validity of Self-Report Questionnaires as Indicators of Fatigue in RYR1-Related Disorders [J].

Kuo, Anna ;

Todd, Joshua J. ;

Witherspoon, Jessica W. ;

Lawal, Tokunbor A. ;

Elliott, Jeffery ;

Chrismer, Irene C. ;

Shelton, Monique O. ;

Razaqyar, Muslima S. ;

Jain, Minal S. ;

Vasavada, Ruhi ;

Waite, Melissa ;

Drinkard, Bart ;

Michael, Darren ;

Richarte, Alicia ;

Bonnemann, Carsten G. ;

Meilleur, Katherine G. .

JOURNAL OF NEUROMUSCULAR DISEASES, 2019, 6 (01) :133-141

[46] Physiological role for S-nitrosylation of RyR1 in skeletal muscle function and development [J].

Sun, Qi-An ;

Grimmett, Zachary W. ;

Hess, Douglas T. ;

Perez, Lautaro G. ;

Qian, Zhaoxia ;

Chaube, Ruchi ;

Venetos, Nicholas M. ;

Plummer, Bradley N. ;

Laurita, Kenneth R. ;

Premont, Richard T. ;

Stamler, Jonathan S. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 723

[47] Functional Studies of RYR1 Mutations in the Skeletal Muscle Ryanodine Receptor Using Human RYR1 Complementary DNA [J].

Sato, Keisaku ;

Pollock, Neil ;

Stowell, Kathryn M. .

ANESTHESIOLOGY, 2010, 112 (06) :1350-1354

[48] King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene [J].

Dowling, James J. ;

Lillis, Suzanne ;

Amburgey, Kimberley ;

Zhou, Haiyan ;

Al-Sarraj, Safa ;

Buk, Stefan J. A. ;

Wraige, Elizabeth ;

Chow, Gabby ;

Abbs, Stephen ;

Leber, Steven ;

Lachlan, Katherine ;

Baralle, Diana ;

Taylor, Alexandra ;

Sewry, Caroline ;

Muntoni, Francesco ;

Jungbluth, Heinz .

NEUROMUSCULAR DISORDERS, 2011, 21 (06) :420-427

[49] Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle [J].

Perez, CF ;

López, JR ;

Allen, PD .

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (03) :C640-C649

[50] A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene [J].

Loseth, Sissel ;

Voermans, Nicol C. ;

Torbergsen, Torberg ;

Lillis, Sue ;

Jonsrud, Christoffer ;

Lindal, Sigurd ;

Kamsteeg, Erik-Jan ;

Lammens, Martin ;

Broman, Marcus ;

Dekomien, Gabriele ;

Maddison, Paul ;

Muntoni, Francesco ;

Sewry, Caroline ;

Radunovic, Aleksandar ;

de Visser, Marianne ;

Straub, Volker ;

van Engelen, Baziel ;

Jungbluth, Heinz .

JOURNAL OF NEUROLOGY, 2013, 260 (06) :1504-1510

← 1 2 3 4 5 →